Citations

Citations to this article as recorded by  

• Unconventional secretion of α-synuclein mediated by palmitoylated DNAJC5 oligomers
  Shenjie Wu, Nancy C Hernandez Villegas, Daniel W Sirkis, Iona Thomas-Wright, Richard Wade-Martins, Randy Schekman
  eLife.2023;[Epub]     CrossRef
• Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson’s Disease
  Rui Huang, Yuyuan Gao, Qingrui Duan, Qingxi Zhang, Peikun He, Jianing Chen, Guixian Ma, Limin Wang, Yuhu Zhang, Kun Nie, Lijuan Wang
  Molecular Neurobiology.2023; 60(2): 979.     CrossRef
• Impaired dopamine release in Parkinson’s disease
  Kaitlyn M L Cramb, Dayne Beccano-Kelly, Stephanie J Cragg, Richard Wade-Martins
  Brain.2023; 146(8): 3117.     CrossRef
• Traumatic brain injury and the development of parkinsonism: Understanding pathophysiology, animal models, and therapeutic targets
  Smrithi Padmakumar, Praveen Kulkarni, Craig F. Ferris, Benjamin S. Bleier, Mansoor M. Amiji
  Biomedicine & Pharmacotherapy.2022; 149: 112812.     CrossRef
• Neuroprotective Effects of a Novel Demeclocycline Derivative Lacking Antibiotic Activity: From a Hit to a Promising Lead Compound
  Rodrigo Tomas-Grau, Florencia González-Lizárraga, Diego Ploper, César L. Avila, Sergio B. Socías, Pierre Besnault, Aurore Tourville, Rosa M. Mella, Patricia Villacé, Clarisa Salado, Clémence Rose, Blandine Seon-Méniel, Jean-Michel Brunel, Laurent Ferrié,
  Cells.2022; 11(17): 2759.     CrossRef
• Intracranial administration of alpha-synuclein fibrils in A30P-synuclein transgenic mice causes robust synucleinopathy and microglial induction
  Renee C Gentzel, Dawn Toolan, Sarah Jinn, Joel B Schachter, Lei Ma, Philipp J Kahle, Sean M Smith, Jacob N Marcus
  Neurobiology of Aging.2021; 106: 12.     CrossRef
• Functions of Intracellular Alpha-Synuclein in Microglia: Implications for Parkinson’s Disease Risk
  Alix Booms, Gerhard A. Coetzee
  Frontiers in Cellular Neuroscience.2021;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Glial senescence enhances α-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction
  Bin Hong, Yosuke Ohtake, Takahide Itokazu, Toshihide Yamashita
  Cell Death Discovery.2024;[Epub]     CrossRef
• A Surface Imprinted Polymer EIS Sensor for Detecting Alpha-Synuclein, a Parkinson’s Disease Biomarker
  Roslyn Simone Massey, Rishabh Ramesh Appadurai, Ravi Prakash
  Micromachines.2024; 15(2): 273.     CrossRef
• Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
  Nasir Uddin Mahbub, Md Minarul Islam, Seong-Tshool Hong, Hea-Jong Chung
  Frontiers in Cellular and Infection Microbiology.2024;[Epub]     CrossRef
• Neuropathogenesis-on-chips for neurodegenerative diseases
  Sarnai Amartumur, Huong Nguyen, Thuy Huynh, Testaverde S. Kim, Ran-Sook Woo, Eungseok Oh, Kyeong Kyu Kim, Luke P. Lee, Chaejeong Heo
  Nature Communications.2024;[Epub]     CrossRef
• Systemic inflammation activates coagulation and immune cell infiltration pathways in brains with propagating α-synuclein fibril aggregates
  Anne-Line Strange Laursen, Mikkel Vestergaard Olesen, Jonas Folke, Tomasz Brudek, Luisa Harriet Knecht, Florence Sotty, Kate Lykke Lambertsen, Karina Fog, Louise Torp Dalgaard, Susana Aznar
  Molecular and Cellular Neuroscience.2024; 129: 103931.     CrossRef
• Non-invasive Monitoring of α-Synuclein in Saliva for Parkinson’s Disease Using Organic Electrolyte-Gated FET Aptasensor
  Roslyn S. Massey, Erin M. McConnell, Dennis Chan, Matthew R. Holahan, Maria C. DeRosa, Ravi Prakash
  ACS Sensors.2023; 8(8): 3116.     CrossRef
• CSF-derived extracellular vesicles from patients with Parkinson’s disease induce symptoms and pathology
  Shay Herman, Ruth Djaldetti, Brit Mollenhauer, Daniel Offen
  Brain.2023; 146(1): 209.     CrossRef
• Overexpression-Induced α-Synuclein Brain Spreading
  Rita Pinto-Costa, Eugenia Harbachova, Pietro La Vitola, Donato A. Di Monte
  Neurotherapeutics.2023; 20(1): 83.     CrossRef
• The Role of α-Synuclein in the Regulation of Serotonin System: Physiological and Pathological Features
  Lluis Miquel-Rio, Unai Sarriés-Serrano, Rubén Pavia-Collado, J Javier Meana, Analia Bortolozzi
  Biomedicines.2023; 11(2): 541.     CrossRef
• α‐Synuclein decoy peptide protects mice against α‐synuclein‐induced memory loss
  Qingyun Guo, Ichiro Kawahata, Wenbin Jia, Haoyang Wang, An Cheng, Yasushi Yabuki, Norifumi Shioda, Kohji Fukunaga
  CNS Neuroscience & Therapeutics.2023; 29(6): 1547.     CrossRef
• Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease
  Aron Emmi, Michele Sandre, Francesco Paolo Russo, Giulia Tombesi, Federica Garrì, Marta Campagnolo, Miryam Carecchio, Roberta Biundo, Gaya Spolverato, Veronica Macchi, Edoardo Savarino, Fabio Farinati, Piero Parchi, Andrea Porzionato, Luigi Bubacco, Raffa
  Movement Disorders.2023; 38(5): 885.     CrossRef
• Retina-to-brain spreading of α-synuclein after intravitreal injection of preformed fibrils
  Dayana Pérez-Acuña, Ka Hyun Rhee, Soo Jean Shin, Jeeyun Ahn, Jee-Young Lee, Seung-Jae Lee
  Acta Neuropathologica Communications.2023;[Epub]     CrossRef
• Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis
  Matthieu Béreau, Vincent Van Waes, Mathieu Servant, Eloi Magnin, Laurent Tatu, Mathieu Anheim
  Cells.2023; 12(12): 1599.     CrossRef
• Translating Pathological Brain Activity Primers in Parkinson’s Disease Research
  Daniela Mirzac, Svenja L. Kreis, Heiko J. Luhmann, Gabriel Gonzalez-Escamilla, Sergiu Groppa
  Research.2023;[Epub]     CrossRef
• Animal models of Parkinson’s disease: bridging the gap between disease hallmarks and research questions
  Axelle Dovonou, Cyril Bolduc, Victoria Soto Linan, Charles Gora, Modesto R. Peralta III, Martin Lévesque
  Translational Neurodegeneration.2023;[Epub]     CrossRef
• The Poly-Arginine Peptide R18D Interferes with the Internalisation of α-Synuclein Pre-Formed Fibrils in STC-1 Enteroendocrine Cells
  Anastazja M. Gorecki, Holly Spencer, Bruno P. Meloni, Ryan S. Anderton
  Biomedicines.2023; 11(8): 2089.     CrossRef
• Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
  Shuyu Zhang, Karina Dauer, Timo Strohäker, Lars Tatenhorst, Lucas Caldi Gomes, Simon Mayer, Byung Chul Jung, Woojin S. Kim, Seung‐Jae Lee, Stefan Becker, Friederike Liesche‐Starnecker, Markus Zweckstetter, Paul Lingor
  Brain Pathology.2023;[Epub]     CrossRef
• Aging, Parkinson’s Disease, and Models: What Are the Challenges?
  Emily Rocha, Manish Chamoli, Shankar J. Chinta, Julie K. Andersen, Ruby Wallis, Erwan Bezard, Matt Goldberg, Tim Greenamyre, Warren Hirst, We-Li Kuan, Deniz Kirik, Laura Niedernhofer, Irit Rappley, Shalini Padmanabhan, Louis-Eric Trudeau, Maria Spillantin
  Aging Biology.2023; 1(1): 20230010.     CrossRef
• A Novel NOX Inhibitor Alleviates Parkinson’s Disease Pathology in PFF-Injected Mice
  Kwadwo Ofori, Anurupa Ghosh, Dinesh Kumar Verma, Darice Wheeler, Gabriela Cabrera, Jong-Bok Seo, Yong-Hwan Kim
  International Journal of Molecular Sciences.2023; 24(18): 14278.     CrossRef
• Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brain
  Margaux Teil, Sandra Dovero, Mathieu Bourdenx, Marie-Laure Arotcarena, Morgane Darricau, Gregory Porras, Marie-Laure Thiolat, Inés Trigo-Damas, Celine Perier, Cristina Estrada, Nuria Garcia-Carrillo, María Trinidad Herrero, Miquel Vila, José A. Obeso, Erw
  npj Parkinson's Disease.2023;[Epub]     CrossRef
• Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology
  Jun Sung Park, Riaz Ahmad, Kyonghwan Choe, Min Hwa Kang, Tae Ju Park, Myeong Ok Kim
  Vaccines.2023; 11(12): 1820.     CrossRef
• Ellagic Acid Prevents α-Synuclein Spread and Mitigates Toxicity by Enhancing Autophagic Flux in an Animal Model of Parkinson’s Disease
  Nada Radwan, Engila Khan, Mustafa T. Ardah, Tohru Kitada, M. Emdadul Haque
  Nutrients.2023; 16(1): 85.     CrossRef
• DA-9805 protects dopaminergic neurons from endoplasmic reticulum stress and inflammation
  Sora Kang, Ying Piao, Young Cheol Kang, Suyeol Lim, Youngmi Kim Pak
  Biomedicine & Pharmacotherapy.2022; 145: 112389.     CrossRef
• Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells
  Eftychia Vasili, Antonio Dominguez-Meijide, Manuel Flores-León, Mohammed Al-Azzani, Angeliki Kanellidi, Ronald Melki, Leonidas Stefanis, Tiago Fleming Outeiro
  Molecular Neurobiology.2022; 59(2): 1273.     CrossRef
• Phosphorylation of endogenous α-synuclein induced by extracellular seeds initiates at the pre-synaptic region and spreads to the cell body
  Shiori Awa, Genjiro Suzuki, Masami Masuda-Suzukake, Takashi Nonaka, Minoru Saito, Masato Hasegawa
  Scientific Reports.2022;[Epub]     CrossRef
• Evidence of Inflammation in Parkinson’s Disease and Its Contribution to Synucleinopathy
  Thuy Thi Lai, Yun Joong Kim, Hyeo-il Ma, Young Eun Kim
  Journal of Movement Disorders.2022; 15(1): 1.     CrossRef
• α-Synuclein in Parkinson's disease and advances in detection
  Rong Chen, Xuan Gu, Xiaoying Wang
  Clinica Chimica Acta.2022; 529: 76.     CrossRef
• Neurons with Cat’s Eyes: A Synthetic Strain of α-Synuclein Fibrils Seeding Neuronal Intranuclear Inclusions
  Francesca De Giorgi, Muhammed Bilal Abdul-Shukkoor, Marianna Kashyrina, Leslie-Ann Largitte, Francesco De Nuccio, Brice Kauffmann, Alons Lends, Florent Laferrière, Sébastien Bonhommeau, Dario Domenico Lofrumento, Luc Bousset, Erwan Bezard, Thierry Buffete
  Biomolecules.2022; 12(3): 436.     CrossRef
• A Novel NOX Inhibitor Treatment Attenuates Parkinson’s Disease-Related Pathology in Mouse Models
  Anurupa A. Ghosh, Dinesh Kumar Verma, Gabriela Cabrera, Kwadwo Ofori, Karina Hernandez-Quijada, Jae-Kwan Kim, Joo Hee Chung, Michael Moore, Sung Hwan Moon, Jong Bok Seo, Yong-Hwan Kim
  International Journal of Molecular Sciences.2022; 23(8): 4262.     CrossRef
• Do Naturally Occurring Antioxidants Protect Against Neurodegeneration of the Dopaminergic System? A Systematic Revision in Animal Models of Parkinson's Disease
  Carmen Costas, Lilian R.F. Faro
  Current Neuropharmacology.2022; 20(2): 432.     CrossRef
• NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson’s disease
  Min Kyung Song, Levi Adams, Joo Hee Lee, Yoon-Seong Kim, Hemant K. Paudel
  PLOS ONE.2022; 17(7): e0272085.     CrossRef
• Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo
  Rachel E. Lackie, Aline S. de Miranda, Mei Peng Lim, Vladislav Novikov, Nimrod Madrer, Nadun C. Karunatilleke, Benjamin S. Rutledge, Stephanie Tullo, Anne Brickenden, Matthew E. R. Maitland, David Greenberg, Daniel Gallino, Wen Luo, Anoosha Attaran, Irina
  Acta Neuropathologica.2022; 144(5): 881.     CrossRef
• Nanomedicine in the Face of Parkinson’s Disease: From Drug Delivery Systems to Nanozymes
  Francisco J. Padilla-Godínez, Leonardo I. Ruiz-Ortega, Magdalena Guerra-Crespo
  Cells.2022; 11(21): 3445.     CrossRef
• Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview
  Andreza Fabro de Bem, Rachel Krolow, Hémelin Resende Farias, Victória Linden de Rezende, Daniel Pens Gelain, José Cláudio Fonseca Moreira, João Miguel das Neves Duarte, Jade de Oliveira
  Frontiers in Neuroscience.2021;[Epub]     CrossRef
• Role of Liver Growth Factor (LGF) in Parkinson’s Disease: Molecular Insights and Therapeutic Opportunities
  Efthalia Angelopoulou, Yam Nath Paudel, Christina Piperi
  Molecular Neurobiology.2021; 58(7): 3031.     CrossRef
• Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain
  Nelson Ferreira, Nádia Pereira Gonçalves, Asad Jan, Nanna Møller Jensen, Amelia van der Laan, Simin Mohseni, Christian Bjerggaard Vægter, Poul Henning Jensen
  Acta Neuropathologica Communications.2021;[Epub]     CrossRef
• Pharmacological Inhibition of Brain EGFR Activation By a BBB-penetrating Inhibitor, AZD3759, Attenuates α-synuclein Pathology in a Mouse Model of α-Synuclein Propagation
  Omid Tavassoly, Esther del Cid Pellitero, Frederique Larroquette, Eddie Cai, Rhalena A. Thomas, Vincent Soubannier, Wen Luo, Thomas M. Durcan, Edward A. Fon
  Neurotherapeutics.2021; 18(2): 979.     CrossRef
• The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and Suitability
  Christine Girges, Nirosen Vijiaratnam, Dilan Athauda, Grace Auld, Sonia Gandhi, Thomas Foltynie
  Drugs & Aging.2021; 38(5): 355.     CrossRef
• Prodromal neuroinvasion of pathological α-synuclein in brainstem reticular nuclei and white matter lesions in a model of α-synucleinopathy
  Nelson Ferreira, Mette Richner, Amelia van der Laan, Ida Bergholdt Jul Christiansen, Christian B Vægter, Jens R Nyengaard, Glenda M Halliday, Joachim Weis, Benoit I Giasson, Ian R Mackenzie, Poul H Jensen, Asad Jan
  Brain Communications.2021;[Epub]     CrossRef
• Impact of the apelin/APJ axis in the pathogenesis of Parkinson’s disease with therapeutic potential
  Efthalia Angelopoulou, Yam Nath Paudel, Anastasia Bougea, Christina Piperi
  Journal of Neuroscience Research.2021; 99(9): 2117.     CrossRef
• Adenovirus-induced Reactive Astrogliosis Exacerbates the Pathology of Parkinson’s Disease
  Heeyoung An, Hyowon Lee, Seulkee Yang, Woojin Won, C. Justin Lee, Min-Ho Nam
  Experimental Neurobiology.2021; 30(3): 222.     CrossRef
• Brain iron enrichment attenuates α‐synuclein spreading after injection of preformed fibrils
  Karina Dauer née Joppe, Lars Tatenhorst, Lucas Caldi Gomes, Shuyu Zhang, Mojan Parvaz, Eleonora Carboni, Anna‐Elisa Roser, Hazem El DeBakey, Mathias Bähr, Katarina Vogel‐Mikuš, Chi Wang Ip, Stefan Becker, Markus Zweckstetter, Paul Lingor
  Journal of Neurochemistry.2021; 159(3): 554.     CrossRef
• Increased oscillatory power in a computational model of the olfactory bulb due to synaptic degeneration
  J. Kendall Berry, Daniel Cox
  Physical Review E.2021;[Epub]     CrossRef
• Combining Automated Organoid Workflows with Artificial Intelligence‐Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High‐Throughput Screens for Parkinson's Disease and Beyond
  Henrik Renner, Hans R. Schöler, Jan M. Bruder
  Movement Disorders.2021; 36(12): 2745.     CrossRef
• Is Multiple System Atrophy a Prion-like Disorder?
  Kurt A. Jellinger, Gregor K. Wenning, Nadia Stefanova
  International Journal of Molecular Sciences.2021; 22(18): 10093.     CrossRef
• Cortical alpha-synuclein preformed fibrils do not affect interval timing in mice
  Qiang Zhang, Hisham Abdelmotilib, Travis Larson, Cameron Keomanivong, Mackenzie Conlon, Georgina M. Aldridge, Nandakumar S. Narayanan
  Neuroscience Letters.2021; 765: 136273.     CrossRef
• Temporal Evolution of Inflammation and Neurodegeneration With Alpha-Synuclein Propagation in Parkinson's Disease Mouse Model
  Thuy Thi Lai, Yun Joong Kim, Phuong Thi Nguyen, Young Ho Koh, Tinh Thi Nguyen, Hyeo-il Ma, Young Eun Kim
  Frontiers in Integrative Neuroscience.2021;[Epub]     CrossRef
• The Concept of α-Synuclein Strains and How Different Conformations May Explain Distinct Neurodegenerative Disorders
  Katja Malfertheiner, Nadia Stefanova, Antonio Heras-Garvin
  Frontiers in Neurology.2021;[Epub]     CrossRef
• A historical review of multiple system atrophy with a critical appraisal of cellular and animal models
  David J. Marmion, Wouter Peelaerts, Jeffrey H. Kordower
  Journal of Neural Transmission.2021; 128(10): 1507.     CrossRef
• Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines
  Masaru Tanaka, József Toldi, László Vécsei
  International Journal of Molecular Sciences.2020; 21(7): 2431.     CrossRef
• Modeling Parkinson’s Disease With the Alpha-Synuclein Protein
  Mónica Gómez-Benito, Noelia Granado, Patricia García-Sanz, Anne Michel, Mireille Dumoulin, Rosario Moratalla
  Frontiers in Pharmacology.2020;[Epub]     CrossRef
• Enhanced Susceptibility of PINK1 Knockout Rats to α-Synuclein Fibrils
  Rose B. Creed, Matthew S. Goldberg
  Neuroscience.2020; 437: 64.     CrossRef
• Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
  Yuan Guan, Xiaofang Zhao, Fengwei Liu, Shuxin Yan, Yalong Wang, Cuilian Du, Xiuyu Cui, Rena Li, Claire Xi Zhang
  Frontiers in Cellular Neuroscience.2020;[Epub]     CrossRef
• Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
  Alessia Indrieri, Rocco Pizzarelli, Brunella Franco, Elvira De Leonibus
  Frontiers in Neuroscience.2020;[Epub]     CrossRef
• Classic and evolving animal models in Parkinson's disease
  Tanvi Pingale, Girdhari Lal Gupta
  Pharmacology Biochemistry and Behavior.2020; 199: 173060.     CrossRef

Citations

Citations to this article as recorded by  

• Aggregation-Induced Emission Luminogens: A New Possibility for Efficient Visualization of RNA in Plants
  Zheng-Chao Yang, Li-Xiang Zhao, Yu-Qi Sang, Xin Huang, Xuan-Chen Lin, Zhi-Ming Yu
  Plants.2024; 13(5): 743.     CrossRef
• Immunisation with UB-312 in the Thy1SNCA mouse prevents motor performance deficits and oligomeric α-synuclein accumulation in the brain and gut
  Jacqui T. Nimmo, Harry Smith, Chang Yi Wang, Jessica L. Teeling, James A. R. Nicoll, Ajay Verma, Jean-Cosme Dodart, Zhi Liu, Feng Lin, Roxana O. Carare
  Acta Neuropathologica.2022; 143(1): 55.     CrossRef
• Autophagy-Related Pathways in Vesicular Unconventional Protein Secretion
  Shin Hye Noh, Ye Jin Kim, Min Goo Lee
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson’s Disease
  Irene Sanchez-Mirasierra, Saurav Ghimire, Sergio Hernandez-Diaz, Sandra-Fausia Soukup
  Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
• A quantitative systems pharmacology model for simulating OFF-Time in augmentation trials for Parkinson’s disease: application to preladenant
  Rachel Rose, Emma Mitchell, Piet Van Der Graaf, Daisuke Takaichi, Jun Hosogi, Hugo Geerts
  Journal of Pharmacokinetics and Pharmacodynamics.2022; 49(6): 593.     CrossRef
• Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases
  Falguni Baidya, Mariya Bohra, Aishika Datta, Deepaneeta Sarmah, Birva Shah, Priya Jagtap, Swapnil Raut, Ankan Sarkar, Upasna Singh, Kiran Kalia, Anupom Borah, Xin Wang, Kunjan R. Dave, Dileep R. Yavagal, Pallab Bhattacharya
  Immunology.2021; 162(2): 160.     CrossRef
• Electrogastrography for diagnosis of early-stage Parkinson's disease
  Nobuyuki Araki, Yoshitaka Yamanaka, Anupama Poudel, Yoshikatsu Fujinuma, Akira Katagiri, Satoshi Kuwabara, Masato Asahina
  Parkinsonism & Related Disorders.2021; 86: 61.     CrossRef
• Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity
  Simona S. Ghanem, Hend S. Fayed, Qi Zhu, Jia-Hong Lu, Nishant N. Vaikath, Janarthanan Ponraj, Said Mansour, Omar M. A. El-Agnaf
  Molecules.2021; 26(12): 3736.     CrossRef
• Tat-p27 Ameliorates Neuronal Damage Reducing α-Synuclein and Inflammatory Responses in Motor Neurons After Spinal Cord Ischemia
  Woosuk Kim, Hyun Jung Kwon, Hyo Young Jung, Kyu Ri Hahn, Seung Myung Moon, Yeo Sung Yoon, In Koo Hwang, Soo Young Choi, Dae Won Kim
  Neurochemical Research.2021; 46(12): 3123.     CrossRef
• Immunotherapies for Parkinson’s Disease: Progression of Clinical Development
  Jet Shee Teng, Yin Yin Ooi, Soi Moi Chye, Anna Pick Kiong Ling, Rhun Yian Koh
  CNS & Neurological Disorders - Drug Targets.2021; 20(9): 802.     CrossRef
• Parkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
  Sheila K. Pirooznia, Liana S. Rosenthal, Valina L. Dawson, Ted M. Dawson, Eric Barker
  Pharmacological Reviews.2021; 73(4): 1204.     CrossRef
• Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?
  Khalil Mallah, Christine Couch, Davis M. Borucki, Amer Toutonji, Mohammed Alshareef, Stephen Tomlinson
  Frontiers in Immunology.2020;[Epub]     CrossRef
• Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
  Miguel Lemos, Serena Venezia, Violetta Refolo, Antonio Heras-Garvin, Sabine Schmidhuber, Armin Giese, Andrei Leonov, Sergey Ryazanov, Christian Griesinger, Gergana Galabova, Guenther Staffler, Gregor Karl Wenning, Nadia Stefanova
  Translational Neurodegeneration.2020;[Epub]     CrossRef
• Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation
  James H. Torpey, Richard M. Meade, Ravina Mistry, Jody M. Mason, Jillian Madine
  Frontiers in Neuroscience.2020;[Epub]     CrossRef
• Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
  Jacqui T. Nimmo, Ajay Verma, Jean-Cosme Dodart, Chang Yi Wang, Jimmy Savistchenko, Ronald Melki, Roxana O. Carare, James A. R. Nicoll
  Alzheimer's Research & Therapy.2020;[Epub]     CrossRef
• Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
  Khosro Jamebozorgi, Eskandar Taghizadeh, Daryoush Rostami, Hosein Pormasoumi, George E. Barreto, Seyed Mohammad Gheibi Hayat, Amirhossein Sahebkar
  Molecular Neurobiology.2019; 56(7): 4799.     CrossRef
• The Associations between Immunological Reactivity to the Haptenation of Unconjugated Bisphenol A to Albumin and Protein Disulfide Isomerase with Alpha-Synuclein Antibodies
  Datis Kharrazian, Martha Herbert, Aristo Vojdani
  Toxics.2019; 7(2): 26.     CrossRef
• Effects of single and combined immunotherapy approach targeting amyloid β protein and α‐synuclein in a dementia with Lewy bodies–like model
  Markus Mandler, Edward Rockenstein, Cassia Overk, Michael Mante, Jazmin Florio, Anthony Adame, Changyoun Kim, Radmila Santic, Achim Schneeberger, Frank Mattner, Sabine Schmidhuber, Gergana Galabova, Brian Spencer, Eliezer Masliah, Robert A. Rissman
  Alzheimer's & Dementia.2019; 15(9): 1133.     CrossRef
• Translational therapies for multiple system atrophy: Bottlenecks and future directions
  Nadia Stefanova
  Autonomic Neuroscience.2018; 211: 7.     CrossRef
• Integrin CD11b mediates α-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway
  Liyan Hou, Xiuqi Bao, Caixia Zang, Hanyu Yang, Fuqiang Sun, Yuning Che, Xuefei Wu, Shao Li, Dan Zhang, Qingshan Wang
  Redox Biology.2018; 14: 600.     CrossRef
• Serum titers of autoantibodies against α-synuclein and tau in child- and adulthood
  Isabell Kuhn, Tobias Rogosch, Theresa I. Schindler, Björn Tackenberg, Michael Zemlin, Rolf F. Maier, Richard Dodel, Yannick Kronimus
  Journal of Neuroimmunology.2018; 315: 33.     CrossRef
• Beneficial Effects of Flavonoids Against Parkinson's Disease
  Un Ju Jung, Sang Ryong Kim
  Journal of Medicinal Food.2018; 21(5): 421.     CrossRef
• Unconventional protein secretion – new insights into the pathogenesis and therapeutic targets of human diseases
  Jiyoon Kim, Heon Yung Gee, Min Goo Lee
  Journal of Cell Science.2018;[Epub]     CrossRef
• Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy
  Martin Kallab, Marcos Herrera-Vaquero, Malin Johannesson, Fredrik Eriksson, Jessica Sigvardson, Werner Poewe, Gregor K. Wenning, Eva Nordström, Nadia Stefanova
  Frontiers in Neuroscience.2018;[Epub]     CrossRef
• Gene therapy for neurological disorders: progress and prospects
  Benjamin E. Deverman, Bernard M. Ravina, Krystof S. Bankiewicz, Steven M. Paul, Dinah W. Y. Sah
  Nature Reviews Drug Discovery.2018; 17(9): 641.     CrossRef
• Combined Active Humoral and Cellular Immunization Approaches for the Treatment of Synucleinopathies
  Edward Rockenstein, Gary Ostroff, Fusun Dikengil, Florentina Rus, Michael Mante, Jazmin Florio, Anthony Adame, Ivy Trinh, Changyoun Kim, Cassia Overk, Eliezer Masliah, Robert A. Rissman
  The Journal of Neuroscience.2018; 38(4): 1000.     CrossRef
• Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects
  Julianna J. Tomlinson, Bojan Shutinoski, Li Dong, Fanyi Meng, Dina Elleithy, Nathalie A. Lengacher, Angela P. Nguyen, Greg O. Cron, Qiubo Jiang, Erik D. Roberson, Robert L. Nussbaum, Nour K. Majbour, Omar M. El-Agnaf, Steffany A. Bennett, Diane C. Lagace,
  Journal of Neural Transmission.2017; 124(6): 721.     CrossRef
• Structure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson’s Disease
  Xiaoli Si, Jiali Pu, Baorong Zhang
  Journal of Movement Disorders.2017; 10(2): 69.     CrossRef
• Membrane Trafficking Illuminates a Path to Parkinson’s Disease
  Takafumi Hasegawa, Naoto Sugeno, Akio Kikuchi, Toru Baba, Masashi Aoki
  The Tohoku Journal of Experimental Medicine.2017; 242(1): 63.     CrossRef
• Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
  J. Teister, F. Anders, S. Beck, S. Funke, H. von Pein, V. Prokosch, N. Pfeiffer, F. Grus
  Scientific Reports.2017;[Epub]     CrossRef
• Impact of aging immune system on neurodegeneration and potential immunotherapies
  Zhanfeng Liang, Yang Zhao, Linhui Ruan, Linnan Zhu, Kunlin Jin, Qichuan Zhuge, Dong-Ming Su, Yong Zhao
  Progress in Neurobiology.2017; 157: 2.     CrossRef
• A novel panel of α-synuclein antibodies reveal distinctive staining profiles in synucleinopathies
  Jess-Karan S. Dhillon, Cara Riffe, Brenda D. Moore, Yong Ran, Paramita Chakrabarty, Todd E. Golde, Benoit I. Giasson, Stephan N. Witt
  PLOS ONE.2017; 12(9): e0184731.     CrossRef
• Vaccination strategies in tauopathies and synucleinopathies
  Anne K. Braczynski, Jörg B. Schulz, Jan‐Philipp Bach
  Journal of Neurochemistry.2017; 143(5): 467.     CrossRef
• Missions of <italic>Journal of Movement Disorders</italic>
  Yun Joong Kim
  Journal of Movement Disorders.2016; 9(1): 1.     CrossRef
• How strong is the evidence that Parkinson's disease is a prion disorder?
  Patrik Brundin, Jiyan Ma, Jeffrey H. Kordower
  Current Opinion in Neurology.2016; 29(4): 459.     CrossRef